معرفی
Romain Siriez is a Researcher at the University of Namur, affiliated with the Namur Thrombosis & Hemostasis Center (NTHC) and Namur Research Institute for Life Sciences (NARILIS). His work focuses on anticoagulant therapy monitoring, thrombosis diagnostics, and pharmacokinetics of direct oral anticoagulants (DOACs), particularly edoxaban.
- Education: Doctor of Biomedical and Pharmaceutical Sciences (2022, University of Namur).
Research interests include optimizing coagulation assays for DOAC-treated patients, assessing activated protein C (APC) resistance, and developing point-of-care diagnostic tools in emergency medicine. His contributions address challenges in plasmatic evaluation of Factor Xa inhibitors, aligning with UN Sustainable Development Goal 3 (Good Health and Well-being).
Selected articles highlight advancements in FibWave technology for thrombophilia diagnostics and chromogenic assays for edoxaban metabolite quantification. These works emphasize diagnostic accuracy, anticoagulant performance, and laboratory hematology.
- Awards:
- MT180 2018 Prize (Ulg-UNamur)
Collaborations include partnerships with the NTHC and international symposiums on laboratory hematology innovations. His research is referenced in clinical guidelines and disseminated through conferences like the European Congress on Thrombosis and Haemostasis (2018) and XXXIInd ISLH Symposium (2019).
